Ottolini M C, Shaer C M, Rushton H G, Majd M, Gonzales E C, Patel K M
Department of General Pediatrics, Children's National Medical Center, Washington, D.C. 20010, USA.
J Pediatr. 1995 Sep;127(3):368-72. doi: 10.1016/s0022-3476(95)70065-x.
To determine whether untreated asymptomatic bacteriuria is associated with renal scarring in children with neuropathic bladders managed with clean intermittent catheterization (CIC).
Retrospective study of 207 patients aged 1 to 30 years (mean 11.9 +/- 5.5 years) treated with CIC for a mean duration of 6.6 +/- 3.9 years by the spina bifida program at Children's National Medical Center. All patients were examined for renal scarring with dimercaptosuccinic acid (DMSA) renal scans. Catheterized urine cultures were obtained annually, but bacteriuria ( > 10,000 colony-forming units of a single organism per milliliter) was treated only if the patients had symptoms or if vesicoureteral reflux (VUR) was present.
Of 207 children, 176 (85%) had one or more episodes of untreated asymptomatic bacteriuria and 72 (35%) had one or more febrile episodes associated with positive urine culture results. Biannual DMSA scans detected 54 new scarring episodes in 42 patients. Of newly recognized scars, 55% were preceded within 1 year by a febrile infection, 26% were detected in patients with VUR and asymptomatic bacteriuria, and 19% were detected in new patients during their initial examination. Univariate analysis revealed that new scarring was present in 35 of 176 patients with asymptomatic bacteriuria compared with 7 of 31 patients without (p = 809). Logistic regression analysis revealed that factors associated with scarring were febrile infections (adjusted odds ratio [OR] = 30.6, 95% confidence interval [CI] = 9.8 to 95.8), age more than 20 years (OR = 4.3, CI = 1.01 to 18.5), the presence of bladder trabeculation (OR = 2.7, CI = 1.0 to 7.6), and VUR (OR = 58.8, CI = 6.3 to 547.3), but asymptomatic bacteriuria was not associated with scarring.
In the absence of VUR, asymptomatic bacteriuria in patients undergoing CIC is not a significant risk factor for scarring and does not require antibiotic therapy.
确定在采用清洁间歇性导尿(CIC)治疗的神经性膀胱患儿中,未经治疗的无症状菌尿是否与肾瘢痕形成有关。
对儿童国家医疗中心脊柱裂项目治疗的207例年龄1至30岁(平均11.9±5.5岁)患者进行回顾性研究。这些患者接受CIC治疗的平均时长为6.6±3.9年。所有患者均用二巯基丁二酸(DMSA)肾扫描检查肾瘢痕形成情况。每年进行导尿尿液培养,但仅在患者出现症状或存在膀胱输尿管反流(VUR)时才治疗菌尿(每毫升单一微生物菌落形成单位>10,000)。
207名儿童中,176名(85%)有一次或多次未经治疗的无症状菌尿发作,72名(35%)有一次或多次与尿培养阳性结果相关的发热发作。每半年一次的DMSA扫描在42名患者中检测到54次新的瘢痕形成发作。在新发现的瘢痕中,55%在1年内有发热感染史,26%在有VUR和无症状菌尿的患者中检测到,19%在新患者初次检查时检测到。单因素分析显示,176例无症状菌尿患者中有35例出现新的瘢痕形成,而31例无无症状菌尿的患者中有7例出现新的瘢痕形成(p = 0.009)。逻辑回归分析显示,与瘢痕形成相关的因素有发热感染(校正比值比[OR]=30.6,95%置信区间[CI]=9.8至95.8)、年龄超过20岁(OR = 4.3,CI = 1.01至18.5)、膀胱小梁形成(OR = 2.7,CI = 1.0至7.6)和VUR(OR = 58.8,CI = 6.3至547.3),但无症状菌尿与瘢痕形成无关。
在无VUR的情况下,接受CIC治疗的患者无症状菌尿不是瘢痕形成的重要危险因素,不需要抗生素治疗。